Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A<sub>2A</sub> Receptor Inverse Agonists
The therapeutic use of A<sub>2A</sub> adenosine receptor (AR) antagonists for the treatment of neurodegenerative disorders, such as Parkinson and Alzheimer diseases, is a very promising approach. Moreover, the potential therapeutic role of A<sub>2A</sub> AR antagonists to avo...
Հիմնական հեղինակներ: | Flavia Varano, Daniela Catarzi, Erica Vigiani, Fabrizio Vincenzi, Silvia Pasquini, Katia Varani, Vittoria Colotta |
---|---|
Ձևաչափ: | Հոդված |
Լեզու: | English |
Հրապարակվել է: |
MDPI AG
2020-07-01
|
Շարք: | Pharmaceuticals |
Խորագրեր: | |
Առցանց հասանելիություն: | https://www.mdpi.com/1424-8247/13/8/161 |
Նմանատիպ նյութեր
-
Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A<sub>1</sub> and A<sub>2A</sub> Receptors, and Efficacy in Animal Models of Depression
: Flavia Varano, և այլն
Հրապարակվել է: (2021-07-01) -
A<sub>2A</sub> Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease
: Stefania Gessi, և այլն
Հրապարակվել է: (2021-09-01) -
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles
: Lucia Squarcialupi, և այլն
Հրապարակվել է: (2017-01-01) -
A<sub>3</sub> Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
: Andrea Spinaci, և այլն
Հրապարակվել է: (2022-01-01) -
How Are Adenosine and Adenosine A<sub>2A</sub> Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?
: Akihisa Mori, և այլն
Հրապարակվել է: (2021-08-01)